Manufacturer
GLAXOSMITHKLINE PHARMACEUTICALS SA
Contents
Lamivudine 150 mg, zidovudine 300 mg
Indication
HIV infection.
Instruction
May be taken with or without food.
Drug interaction
Lamivudine: Decreased AUC & Cmax w/ sorbitol. Increased exposure w/ trimethoprim/sulphamethoxazole. Inhibited intracellular phosphorylation of emtricitabine. Zidovudine: Decreased metabolism rate by atovaquone. Reduced absorption by clarithromycin. Low phenytoin blood levels. Reduced renal excretion w/ probenecid. Inhibited intracellular phosphorylation of
Malaysia
